Prostate interventions in patients with mild haemophilia: Safe and feasible.
biopsy
haemophilia A
haemophilia B
laser therapy
prostate
prostatectomy
transurethral resection of prostate
Journal
Haemophilia : the official journal of the World Federation of Hemophilia
ISSN: 1365-2516
Titre abrégé: Haemophilia
Pays: England
ID NLM: 9442916
Informations de publication
Date de publication:
Nov 2021
Nov 2021
Historique:
revised:
15
07
2021
received:
26
04
2021
accepted:
16
07
2021
pubmed:
4
8
2021
medline:
11
11
2021
entrez:
3
8
2021
Statut:
ppublish
Résumé
To date, there is no specific recommendation or evaluation of the morbidity of prostate surgery in patients with haemophilia (PWH) although this surgery is common and at high risk of bleeding. To assess the post-operative morbidity of benign prostate hyperplasia (BPH) surgeries and of oncological prostate interventions in patients with mild haemophilia A or B. We performed a monocentre, epidemiological, in real life study. Data were collected between 1 January, 1997 and 1 September, 2020 and focused on prostate biopsy, radical prostatectomy, prostate radiotherapy, simple prostatectomy, transurethral resection of prostate (TURP) and laser-vaporisation in patients with mild haemophilia A or B. Between 1 January, 1997 and 1 September, 2020, 51 interventions were performed on 30 patients with mild haemophilia. Haemophilia A represented 93.33% of the population and haemophilia B 6.67%. For prostate biopsies (n = 24), median length of hospitalisation was 4 days and only one patient needed a blood transfusion. No patient needed re-admission. For prostatectomy (n = 10), one patient presented with intra-operative and post-operative bleeding. Two patients required re-admission. The other patients did not present any significant haemorrhagic symptoms. For radiotherapy (n = 4), two patients presented a grade II complication (radiocystitis and radiorectitis). For BPH surgeries, during hospitalisation, laser-vaporisation (n = 5) was less haemorrhagic than TURP (n = 5) but after hospital discharge, 60% of patients presented a haemorrhagic complication with two readmissions and one surgical re-explorations. Performed in a specialised centre, prostate surgeries and interventions in patients with mild haemophilia is feasible with acceptable morbidity.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e659-e666Informations de copyright
© 2021 John Wiley & Sons Ltd.
Références
Mottet N, Bellmunt J, Bolla M, et al. EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent. Eur Urol. 2017;71(4):618-629.
Chapple C, Abrams P, Male Lower Urinary Tract Symptoms (LUTS) [Online]. 2012 [cited 14 dec 2020]; URL: www.siu-urology.org
Vuichoud C, Loughlin KR. Benign prostatic hyperplasia: epidemiology, economics and evaluation. Can J Urol. 2015;22(Suppl 1):1-6.
Reich O, Gratzke C, Bachmann A, et al. Morbidity, mortality and early outcome of transurethral resection of the prostate: a prospective multicenter evaluation of 10,654 patients. J Urol. 2008;180(1):246-249.
Rainwater LM, Segura JW. Technical consideration in radical retropubic prostatectomy: blood loss after ligation of dorsal venous complex. J Urol. 1990;143(6):1163-1165.
Iorio A, Stonebraker JS, Chambost H, et al. Establishing the prevalence and prevalence at birth of hemophilia in males: a meta-analytic approach using national registries. Ann Intern Med. 2019;171(8):540-546.
Biron-Andreani C, de Moerloose P, D'oiron R, et al. Cancer detection and management in patients with haemophilia: a retrospective European multicentre study. Haemophilia Janv. 2014;20(1):78-82.
Coppola A, Windyga J, Tufano A, Yeung C, Di Minno M. Treatment for preventing bleeding in people with haemophilia or other congenital bleeding disorders undergoing surgery. Cochrane Cystic Fibrosis and Genetic Disorders Group, éditeur. Cochrane Database of Systematic Reviews [online]. 9 févr 2015 [cited 27 sept 2020]; URL: http://doi.wiley.com/10.1002/14651858.CD009961.pub2
Srivastava A, Santagostino E, Dougall A, et al. WFH guidelines for the management of hemophilia. Haemophilia. 2020;26(S6):1-158.
Fogarty PF, Kouides P. How we manage prostate biopsy and prostate cancer therapy in men with haemophilia: managing prostate issues in men with a hemophilia. Haemophilia. 2012;18(3):e88-e90.
Lavery HJ, Senaratne P, Gainsburg DM, Samadi D. Robotic prostatectomy in a patient with hemophilia. JSLS. 2010;14(3):439-441.
Rogenhofer S, Hauser S, Breuer A, et al. Urological surgery in patients with hemorrhagic bleeding disorders hemophilia A, hemophilia B, von Willebrand disease: a retrospective study with matched pairs analysis. World J Urol. 2013;31(3):703-707.
Benoit G, Lambert T, Blanchet P, et al. Quels traitements urologiques sont possibles chez un hémophile?. Prog Urol. 2000;10:388-396.
Clavien PA, Barkun J, De Oliveira ML, et al. The clavien-dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250(2):187-196.
Rigaud J, Hetet J-F, Bouchot O. Prise en charge de la cystite radique. Prog Urol. 2004;5.
Samama C-M, Albaladejo P, Laversin S, Marret E. Prévention de la maladie thromboembolique veineuse périopératoire et obstétricale. Ann Fr Anesth Reanim. 2005;24(8):853-861.
Borghesi M, Ahmed H, Nam R, et al. Complications after systematic, random, and image-guided prostate biopsy. Eur Urol. 2017;71(3):353-365.
Saito K, Washino S, Nakamura Y, et al. Transperineal ultrasound-guided prostate biopsy is safe even when patients are on combination antiplatelet and/or anticoagulation therapy. BMC Urol. 2017;17(1):53.
Novara G, Ficarra V, Rosen RC, et al. Systematic review and meta-analysis of perioperative outcomes and complications after robot-assisted radical prostatectomy. Eur Urol. 2012;62(3):431-452.
Cornu J-N, Ahyai S, Bachmann A, et al. A systematic review and meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic obstruction: an update. Eur Urol. 2015;67(6):1066-1096.
Descazeaud A, Robert G, Azzousi AR, et al. Laser treatment of benign prostatic hyperplasia in patients on oral anticoagulant therapy: a review. BJU Int. 2009;103(9):1162-1165.
Thomas JA, Tubaro A, Barber N, et al. A multicenter randomized noninferiority trial comparing GreenLight-XPS laser vaporization of the prostate and transurethral resection of the prostate for the treatment of benign prostatic obstruction: two-year outcomes of the GOLIATH Study. Eur Urol. 2016;69(1):94-102.
Lee DJ, Rieken M, Halpern J, et al. Laser vaporization of the prostate with the 180-W XPS-Greenlight laser in patients with ongoing platelet aggregation inhibition and oral anticoagulation. Urology. 2016;91:167-173.
Sorokin I, Sundaram V, Singla N, et al. Robot-assisted versus open simple prostatectomy for benign prostatic hyperplasia in large glands: a propensity score-matched comparison of perioperative and short-term outcomes. J Endourol. 2017;31(11):1164-1169.
Knight GM, Talwar A, Salem R, Mouli S. Systematic review and meta-analysis comparing prostatic artery embolization to gold-standard transurethral resection of the prostate for benign prostatic hyperplasia. Cardiovasc Intervent Radiol. 2021;44(2):183-193.
Uflacker A, Haskal ZJ, Bilhim T, Patrie J, Huber T, Pisco JM. Meta-Analysis of prostatic artery embolization for benign prostatic hyperplasia. J Vasc Interv Radiol. 2016;27(11):1686-1697.
Shin MG. Single-center retrospective study of preoperative prostatic artery embolization with the use of gelatin sponge: initial experience and influence for blood loss in prostate surgery. J Vasc Interv Radiol. 2019;30(5):6.